STING dampens unfolded protein response to enable MHC-I presentation of self-antigens in inflammation
Background
The adaptive immune system contributes significantly to Parkinson's disease (PD) pathogenesis, with mitochondrial antigens (MitAP) presented on MHC-I molecules implicated. Previous work showed that the PD-associated protein PINK1 negatively regulates this presentation. Understanding the precise mechanisms governing MitAP presentation is crucial, as its dysregulation can lead to cytotoxic CD8+ T cell stimulation and neuroinflammation, contributing to motor impairments. This study explores how innate immune pathways, specifically cGAS-STING, modulate the cellular stress response to influence self-antigen presentation.
Study Design
Researchers investigated the role of cGAS-STING signaling in regulating mitochondrial antigen (MitAP) presentation on MHC-I molecules. They utilized in vivo mouse models, including PINK1-deficient mice, to study the effects of MitAP activation. Inflammation was induced via TLR4 activation. The study compared outcomes in wild-type mice versus those with genetic ablation of STING, assessing parameters like UPR activity, expression of transcription factors such as XBP1s, and the repertoire of peptides displayed on the cell surface. CD8+ T cell stimulation and motor impairments were also evaluated in the context of MitAP activation.
Results
The study revealed that following TLR4 activation, mitochondrial antigen (MitAP) presentation is regulated through a pathway involving cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING). STING acts as a rheostat, dampening the unfolded protein response (UPR). Without STING, the cellular stress response is significantly amplified, leading to a translational attenuation that inhibits the expression of XBP1s, a transcription factor essential for MitAP presentation. This indicates a critical role for STING in maintaining the balance required for proper antigen display. > STING activity directly regulates the repertoire of peptides displayed at the cell surface during inflammation, highlighting its potential role in immunosurveillance. In PINK1-deficient mice, MitAP activation led to cytotoxic CD8+ T cell stimulation and severe motor impairments, which were reversible by L-DOPA, further linking this pathway to PD pathology.
Key Findings
- STING dampens the unfolded protein response (UPR) following TLR4 activation.
- STING's dampening effect on UPR is crucial for the presentation of mitochondrial antigens (MitAP) on MHC-I.
- Absence of STING amplifies UPR, leading to translational attenuation and inhibited
XBP1sexpression, which is required for MitAP. - STING activity regulates the repertoire of peptides displayed on the cell surface during inflammation.
- MitAP activation in PINK1-deficient mice caused cytotoxic CD8+ T cell stimulation and L-DOPA-reversible motor impairments.
Why It Matters
This research fundamentally shifts our understanding of how innate immune pathways like cGAS-STING intersect with cellular stress responses to regulate self-antigen presentation. For individuals with Parkinson's disease and autoimmune conditions, this mechanism offers a novel therapeutic target. Modulating STING activity or the UPR could potentially prevent aberrant self-antigen presentation, thereby reducing detrimental CD8+ T cell responses and neuroinflammation. Targeting STING or the UPR could offer a strategy to control autoimmune processes and slow neurodegeneration in PD, moving beyond symptomatic treatments. This opens avenues for developing interventions that specifically fine-tune immune responses to self-antigens, rather than broadly suppressing immunity.
sting
unfolded-protein-response
mhc-i
self-antigens
parkinsons-disease
autoimmune-disease